Stories

Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.

This week's research roundup features: In vitro activity of a hypochlorous acid-generating electrochemical bandage against yeast biofilms

As a clinical specialty representative for Mayo Clinic Laboratories, Doug Smith works to promote Mayo Clinic’s core values and support community-based health care and integrated delivery systems through the sale of Mayo Clinic Laboratories tests.

This week's research roundup features: Clinical impact of KIR haplotypes in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic hematopoietic stem cell transplantation

Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by Mayo Clinic Laboratories gave them the confirmatory diagnosis they needed.

This week's research roundup features: AMPK: The key to ischemia-reperfusion injury

This week's research roundup features: Progression of chronic kidney disease following radical and partial nephrectomy

Michael Baisch has been a systems engineer in the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic for 18 years. Michael partners with the laboratories and business offices to evaluate their workflows for optimal quality, efficiency, and cost. He strives to improve processes so the entire team can get results into the hands of the patient and their care team in an accurate, timely, and cost-effective manner.

This week's research roundup features: Renin production by juxtaglomerular cell tumors and clear cell renal cell carcinoma and the role of angiotensin signaling inhibitors

Utilizing testing capabilities of two separate laboratory facilities, Mayo Clinic Laboratories’ new serotonin release assay (SRA) is a gold-standard test supported by decades of clinical hematopathologic experience and advanced mass spectrometry testing.

This week's research roundup features: Evaluating the significance of pancreatobiliary fluorescence in situ hybridization polysomy on prognosis in de novo cholangiocarcinoma

Since overcoming a life-threatening diagnosis five years ago, Jim Smith has embraced life. But each time he travels to Mayo Clinic for follow-up laboratory testing, a well of emotions rises up to remind him of life’s fragility. Thankfully, through streamlined, accurate testing and top-notch clinical care, those feelings are generally short-lived.

As an event management coordinator for the Department of Laboratory Medicine and Pathology at Mayo Clinic, Jason Majorowicz acts as an investigator when something may deviate from its established process. With a background in biotechnology and over 20 years of experience at Mayo Clinic, Jason helps with process improvement, quality assurance, and problem-solving.